PMID- 34721588 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20211102 IS - 1687-966X (Print) IS - 1687-9678 (Electronic) VI - 2021 DP - 2021 TI - Human Umbilical Mesenchymal Stromal Cells Mixed with Hyaluronan Transplantation Decreased Cartilage Destruction in a Rabbit Osteoarthritis Model. PG - 2989054 LID - 10.1155/2021/2989054 [doi] LID - 2989054 AB - Osteoarthritis (OA), the most common type of arthritis, causes pain in joints and disability. Due to the absence of ideal effective medication, stem cell transplantation emerges as a new hope for OA therapy. This study is aimed at evaluating the capability of human umbilical cord mesenchymal stromal cells (HUCMSCs) mixed with hyaluronan (HA) to treat osteoarthritis in a rabbit model. Differentiation capability of HUCMSCs, magnetic resonance image examination, and immunohistochemistry of the cartilage after transplantation of HUCMSCs mixed with HA in a rabbit OA model were explored. HUCMSCs exhibited typical mesenchymal stromal cell (MSC) characteristics, including spindle-shaped morphology, surface marker expressions (positive for human leukocyte antigen- (HLA-) ABC, CD44, CD73, CD90, and CD105; negative for HLA-DR, CD34, and CD45), and trilineage differentiation (chondrogenesis, adipogenesis, and osteogenesis). The gene expression of SOX9, type II collagen, and aggrecan in the HUCMSC-derived chondrocytes mixed with HA was increased after in vitro chondrogenesis compared with HUCMSCs. A gross and histological significant improvement in hyaline cartilage destruction after HUCMSCs mixed with HA was noted in the animal model compared to the OA knees. The International Cartilage Repair Society histological score and Safranin O staining were significantly higher for the treated knees than the control knees (p < 0.05). Moreover, the expression of MMP13 was significantly decreased in the treated knees than in the OA knees. In conclusion, HUCMSCs mixed with HA in vitro and in vivo might attenuate the cartilage destruction in osteoarthritis. Our study provided evidence for future clinical trials. CI - Copyright (c) 2021 Yu-Hsun Chang et al. FAU - Chang, Yu-Hsun AU - Chang YH AUID- ORCID: 0000-0001-7762-4469 AD - Department of Pediatrics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan. FAU - Ding, Dah-Ching AU - Ding DC AUID- ORCID: 0000-0001-5105-068X AD - Department of Obstetrics and Gynecology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan. AD - Department of Obstetrics and Gynecology, College of Medicine, Tzu Chi University, Hualien, Taiwan. FAU - Wu, Kun-Chi AU - Wu KC AUID- ORCID: 0000-0001-6252-7957 AD - Department of Orthopedics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan. LA - eng PT - Journal Article DEP - 20211021 PL - United States TA - Stem Cells Int JT - Stem cells international JID - 101535822 PMC - PMC8553511 COIS- The authors declare no conflict of interest. EDAT- 2021/11/02 06:00 MHDA- 2021/11/02 06:01 PMCR- 2021/10/21 CRDT- 2021/11/01 09:13 PHST- 2021/07/09 00:00 [received] PHST- 2021/09/14 00:00 [revised] PHST- 2021/10/05 00:00 [accepted] PHST- 2021/11/01 09:13 [entrez] PHST- 2021/11/02 06:00 [pubmed] PHST- 2021/11/02 06:01 [medline] PHST- 2021/10/21 00:00 [pmc-release] AID - 10.1155/2021/2989054 [doi] PST - epublish SO - Stem Cells Int. 2021 Oct 21;2021:2989054. doi: 10.1155/2021/2989054. eCollection 2021.